Leef Brands (LEEEF) Total Non-Current Liabilities (2023 - 2026)
Leef Brands' (LEEEF) quarterly Total Non-Current Liabilities came in at $36.1 million in Q1 2026, up 0.86% quarter-over-quarter from $35.8 million in Q4 2025.
Leef Brands (LEEEF) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Leef Brands has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $36.1 million for Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $36.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $36.1 million (changed N/A YoY), and the FY2025 annual result was $35.8 million, down 22.9% from the prior year.
- Total Non-Current Liabilities came in at $36.1 million for Q1 2026 at Leef Brands, up from $35.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $46.4 million in Q4 2024 to a low of -$1.9 million in Q4 2023.
- The 4-year median for Total Non-Current Liabilities is $35.9 million (2025), against an average of $29.1 million.
- Across the five-year window, Total Non-Current Liabilities jumped 2489.48% in 2024 and fell 22.9% in 2025, its largest moves.
- Leef Brands' Total Non-Current Liabilities stood at -$1.9 million in 2023, then surged by 2489.48% to $46.4 million in 2024, then retreated by 22.9% to $35.8 million in 2025, then gained by 0.86% to $36.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $36.1 million (Q1 2026), $35.8 million (Q4 2025), and $46.4 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Leef Brands | - | - | 4.62 Mn | 36.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.08 Mn |
| Dec 31, 2025 | 35.78 Mn |
| Dec 31, 2024 | 46.40 Mn |
| Dec 31, 2023 | -1.94 Mn |